---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-238169"
form_type: "8-K"
ticker: "CERS"
cik: "0001020214"
company_name: "CERUS CORP"
filed_at: "2024-10-16T23:59:59+00:00"
generated_at: "2026-05-30T13:33:13.769983+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cerus gets $248M BARDA contract for RBC program; EU CE Mark review denied

## Summary
- New BARDA contract valued up to $248M to support U.S. INTERCEPT RBC system development and PMA submission; $32.1M awarded for base period.
- CE Mark review in Europe closed without approval due to insufficient impurity profile data; company assessing strategy for future filing.
- RedeS Phase 3 trial enrolling at two new sites; timing of completion and PMA submission under assessment due to later-than-expected site activation.
- Company believes positive ReCePI trial data could support broader indication in a future EU CE Mark submission.

## SEC filing metadata
- accession: 0001193125-24-238169
- form_type: 8-K
- ticker: CERS
- cik: 0001020214
- company_name: CERUS CORP
- filed_at: 2024-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1020214/000119312524238169/0001193125-24-238169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1020214/000119312524238169/d856042d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-238169
- JSON: https://secwatch.observer/filing/0001193125-24-238169.json
- Plain text: https://secwatch.observer/filing/0001193125-24-238169.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.